Company Filing History:
6 out of 65 
1 out of 2 
1 out of 1 Years Active: 2018-2024
Title: Zhaoguo Chen: Innovator in Pharmaceutical Chemistry
Introduction
Zhaoguo Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective HER2 inhibitors. With a total of 8 patents, his work has the potential to impact the treatment of various diseases.
Latest Patents
One of Zhaoguo Chen's latest patents is focused on pyrrolo[2,1-f][1,2,4]triazine derivatives that serve as selective HER2 inhibitors. This invention relates to a group of compounds that can be utilized in the preparation of drugs aimed at inhibiting HER2. Specifically, it includes a compound represented by a specific formula, along with its isomers and pharmaceutically acceptable salts. Another notable patent involves a crystal form of a [1,2,4]triazolo[1,5-c]pyrimidine compound, which is disclosed along with its preparation method. This crystal form is intended for use in creating medicaments for treating A-receptor related diseases.
Career Highlights
Zhaoguo Chen has worked with several notable companies in the pharmaceutical industry. He has been associated with Medshine Discovery Inc. and China Resources Pharmaceutical Holdings Company Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Zhaoguo Chen has collaborated with various professionals in his field, including Shuhui Chen and Fang Liu. These collaborations have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Zhaoguo Chen is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in drug development. His contributions, particularly in the area of HER2 inhibitors, showcase his commitment to improving healthcare through innovation.